Connecticut Attorney General William Tong says that money is ‘owed to the victims of the opioid epidemic.’
opioid epidemic
In Cherokee country, opioid crisis seen as existential threat
Data shows that Native Americans had higher rates of overdose deaths from prescription painkillers and illicit opioids than any other racial and ethnic group from 2003 through 2013.
States split by party on accepting Purdue Pharma settlement
Republican state attorneys general chiefly support a tentative multibillion-dollar settlement with the OxyContin maker, while their Democratic counterparts mostly oppose it.
Opioid talks at impasse; Purdue bankruptcy filing expected
Attempts to reach a nationwide settlement over the opioid crisis with OxyContin maker Purdue Pharma have stalled.
Commentary: King bill would ease looming physical therapist shortfall
Encouraging physical therapists to practice in underserved areas by offering them student loan relief would give more Mainers a healthier option to painkilling drugs.
Commentary: Usual responses to drug epidemics won’t reverse fentanyl fatalities
Solutions should focus on creative supply disruption, supervised opioid use sites and new forms of treatment.
Trump administration announces nearly $2 billion in opioid grants
The money is destined for states and local governments to help provide treatment and recovery services.
Rally 4 Recovery set for Sunday
PORTLAND — Portland Recovery Community Center will host the sixth annual Rally 4 Recovery to raise awareness about recovery from addiction from noon to 4 p.m. Sept. 8 at Deering Oaks Park. “The Rally 4 Recovery shares the message of hope, that people experiencing substance use disorders can and do recover,” Leslie Clark, PRCC executive […]
Some states, towns skeptical over proposed opioid settlement
Some state attorneys general and local governments are skeptical of a proposed settlement with OxyContin maker Purdue Pharma over its role in the nation’s opioid addiction crisis.
The Maine Millennial: Accounting for pain got lost amid addiction to profit
Drug companies and liquor bottlers can’t be expected to regulate themselves.